Annual Conference

Sections

Overview

Annual Conference 2022

Date

25-27 April

Venue

SEC Glasgow and online

The UK’s leading rheumatology event will be back in Glasgow next year for a three-day hybrid conference of cutting-edge research, best in the field speakers, posters, symposia, and much more.

The UK's foremost gathering of leading rheumatology professionals, this fantastic three-day event is full of opportunities to learn, share, and network. You will:

Join us at the UK’s biggest rheumatology conference designed for the entire multi-disciplinary team 
Learn from experts in the field about the latest developments in rheumatology and expand your knowledge  
Experience three days of cutting edge research, unrivalled networking, plus posters, symposia, exhibitions and more 
Take part in our popular wellbeing activities
Earn CPD credits

Technology has enabled us to attend conferences and learning events during the past year from the comfort of our own homes, making these activities more accessible and flexible than ever. Whilst we are excited to meet again in person next year for the first time since 2019, we are committed to continuing to offer you the flexibility to choose how you participate in future conferences, online or in person.

2021 programme

Day 1

Day 2

Day 3

Early Morning

SIG sessions

TIME

SESSION

SPEAKERS

08:00-09:00

Ethnicity SIG

Dr Avinash Jain, Dr Arumugam Moorthy and Joti Rehal

08:00-09:00

Vasculitis SIG

Prof Raashid Luqmani, Dr Neil Basu and Francesco Dernie

08:00-09:00

Pregnancy and rheumatic disease SIG

Dr Iona Thorne, Prof Ian Giles and Dr Maria Mouyis

08:00-09:00

Hypermobility syndromes SIG

Dr Alan Hakim, Dr Hanadi Kazkaz and Dr Jessica Eccles

Morning

Includes co-badged EULAR sessions, oral abstracts and Trainees sessions

TIME

SESSION

SPEAKERS

09:00-10:30

The rise of remote rheumatology: how to harness the opportunities of patient-reported data in the post-COVID-19 world

Golda Gibson, Patricia Cornell, Melanie Martin and Dr Julie Gandrup

09:00-10:30

Crystal arthropathies (co-badged with EULAR)

Prof Alexander So, Dr Michelle Hui and Prof Eliseo Pascual

09:00-10:30

COVID-19 and work and musculoskeletal health

Dr Gareth Jones, Prof Stephen Bevan and Stefania D'Angelo

09:00-10:30

Improving quality and developing uniformity in UK rheumatology services

Dr Lesley Kay, Dr Liz Price and Dr Rajan Madhok

09:00-10:30

Registers: oral abstracts

Dr Jon Packham, Dr Maira Karabayas, Dr Stephanie Shoop-Worrall, Dr Kim Lauper and Prof Christopher Edwards

10:35-10:55

Poster showcase: Bone

Dr Sarah Hardcastle (chair)

10:35-10:55

Poster showcase: Education

Dr Spencer Ellis (chair)

11:00-12:30

Physiotherapy interventions in rheumatic and musculoskeletal diseases (RMDs): looking to the future

Melissa Domaille, Will Gregory and Melanie Martin

11:00-12:30

Rheumatoid arthritis: oral abstracts

Dr Ahmad Sherbini, Dr Muhammad Shipa, Najib Naamane, Dr Kevin Winthrop and Dr May Nwe Lwin

11:00-12:30

Preparing for life as a consultant (Trainees session)

Dr Sarah Skeoch, Dr Iona Thorne and Dr David Nicholl

11:00-12:30

Using musculoskeletal disease registers to understand the effect of SARS-CoV2 on health and management (co-badged with EULAR)

Prof Robert Landewé, Dr Anja Strangfeld and Prof Gary Macfarlane

11:00-12:30

Scleroderma SIG

Dr Gerry Coughlan, Dr Elizabeth Renzoni and Prof Maya Buch

12:30-13:20

Reporting on remission: striving for optimal outcomes in today’s world (AbbVie organised promotional meeting discussing AbbVie products. Prescribing information and adverse event reporting can be found at the meeting)

Prof Gerd Burmester, Prof Maya Buch, Prof Philip Conaghan

12:30-13:20

Dose optimisation in axSpA: Looking to the future (UCB organised promotional symposium discussing UCB products; prescribing information and adverse event reporting available at the symposium)

Mariella Frostrup, Prof Karl Gaffney, Dr Helena Marzo-Ortega, Prof Ian Giles

Afternoon

Includes Heberden Round

TIME

SESSION

SPEAKERS

13:30-14:00

Keynote: Exercise is (almost) the best medicine!

Dr Ai Lyn Tan

14:10-15:40

Responding to the COVID-19 pandemic: establishing a remote therapy clinic using video-calling technology and a smartphone disease-tracking application

Emily Rose-Parfitt, Dr Philip Hamann and Dr Wouter Bos

14:10-15:40

Infective and inflammatory lung disease in rheumatology SIG

Dr Gouri Koduri, Dr Clive Kelly and Dr Muddassir Shaikh

14:10-15:40

Assessment of the COVID-19 pandemic impact from the perspective of patients with rheumatic musculoskeletal diseases (REUMAVID) in the UK and in the rest of Europe

Prof Marco Garrido-Cumbrera, Dr Helena Marzo-Ortega and Dr Dale Webb

14:10-15:40

National Early Inflammatory Arthritis Audit data – what does it tell us?

Dr Jo Ledingham, Dr Mark Yates and Paul Amlani-Hatcher

14:10-15:40

Education SIG

Dr David Coady, Prof Andy Hassell and Rosealeen Killick

16:10-17:10

Heberden Round: Making rheumatology work for patients

Prof Karen Walker-Bone

Early Morning

SIG sessions

TIME

SESSION

SPEAKERS

08:00-09:00

Rheumatology in low and middle income countries SIG

Prof Omondi Oyoo, Prof Tony Woolf and Dr Terry Gibson

08:00-09:00

SLE SIG and BILAG investigators meeting

Dr Ian Bruce, Dr Bridget Griffiths and Dr Ed Vital

08:00-09:00

Ultrasound SIG

Dr Andrew Filer, Dr Cristina Estrach and Dr Sarang Chitale

08:00-09:00

Myositis SIG

Dr Alexander Oldroyd, Dr Patrick Gordon, Dr Charalampia Papadopoulou and Dr Michael Reed

Morning

Includes Best abstracts, Essentials and Basic Science sessions

TIME

SESSION

SPEAKERS

09:00-10:30

Fever across the age-groups: is it infection, inflammation or hyperinflammation, and what has COVID-19 taught us?

Dr Jessica Manson, Dr Rachel Tattersall and Dr Philip Riley

09:00-10:30

Symptom management (Essentials session)

Dr James Lilleker, Dr Raj Sengupta and Prof Matthew Collin

09:00-10:30

B-Cell targeted therapies in autoimmune rheumatic diseases

Prof Jo Edwards, Dr Edward Vital and Prof Xavier Mariette

09:00-10:30

From genetics to clinical translation in rheumatic musculoskeletal diseases (Basic science session)

Prof Caroline Ospelt, Dr Louise Reynard and Prof Timothy Vyse

09:00-10:30

Large-vessel vasculitis (co-badged with EULAR)

Dr Christina Duftner, Dr Sarah Mackie and Prof Bernhard Hellmich

10:35-10:55

Poster showcase: Basic science

Prof Tonia Vincent (chair)

10:35-10:55

Poster showcase: Connective tissue diseases

Dr John Pauling (chair)

11:00-12:30

Disease management (Essentials session)

Prof Stefan Siebert, Dr Rachel Hoyles and Dr Christopher Holroyd

11:00-12:30

Spondyloarthropathies SIG

Dr Arumugam Moorthy, Liz Van Rossen and Prof Oliver Fitzgerald

11:00-12:30

Best abstracts: oral abstracts

Melissa Tordoff, Dr Elizabeth Curtis, Balamrit Singh Sokhal, Dr Sarah Bennett and Rebecca Nock

11:00-12:30

What do we need to support self-management?

Emma Dures, Elizabeth Hale and Sarah Ryan

11:00-12:30

Debate: Pain in osteoarthritis – where, why and how? (Basic science session)

Prof David Walsh, Prof Nidhi Sofat, Prof Tonia Vincent and Prof John McBeth

12:30-13:20

SpArking Better Outcomes in AS and PsA: Exploring future possibilities through patient cases (AbbVie organised promotional meeting discussing AbbVie products. Prescribing information and adverse event reporting can be found at the meeting)

Prof Karl Gaffney, Dr Nicola Gullick, Dr Antoni Chan

12:30-13:20

Janssen promotional symposium: From pathogenesis to therapeutic targets, DISCOVER more about targeting IL-23 in psoriatic arthritis (Janssen products will be discussed. Prescribing information and adverse event reporting can be found at the meeting)

Dr Marwan Bukhari, Dr Stephen Kelly

Afternoon

Includes Heberden Oration

TIME

SESSION

SPEAKERS

13:30-14:00

Keynote: First do no harm – the climate emergency is a health emergency

James Dixon

14:10-15:40

Mental health and persistent physical symptoms in inflammatory arthritis: recent insights and implications for practice

Dr Mary Docherty, Dr Sam Norton and Dr Caroline Flurey

14:10-15:40

Pathological mechanisms of systemic lupus erythematosus (SLE) (Basic science session)

Dr Alexander Clarke, Dr Helen Wright and Prof David Hunt

14:10-15:40

Cannabis in rheumatic disease (co-badged with EULAR)

Prof David Finn, Dr Georg Pongratz and Dr Steve Alexander

14:10-15:40

Fast bleep the rheumatologist! Rheumatological emergencies (Trainees session)

Prof Raashid Luqmani, Dr David D'Cruz and Prof Hector Chinoy

14:10-15:40

Adolescent and young adult SIG: developmentally-appropriate healthcare

Dr Lisa Dunkley, Dr Flora McErlane and Dr Corinne Fisher

16:10-17:10

Heberden Oration: A molecular pathology journey into the rheumatoid joint: toward a new taxonomy of disease and precision medicine

Prof Costantino Pitzalis

17:15-18:05

Lilly Symposium Session - How ▼Olumiant® (baricitinib) is changing the way we treat our patients with rheumatoid arthritis

Prof Christopher Edwards, Prof Paul Emery, Prof Peter Taylor

Morning

Includes Droitwich Lecture and Barbara Ansell Address

TIME

SESSION

SPEAKERS

08:10-09:00

Galapagos/Gilead symposium session – Introducing filgotinib, a new advanced therapy option for severe and now moderate rheumatoid arthritis

Prof Peter Taylor, Dr James Galloway, Prof Paul Emery

09:00-10:30

Publish or perish

Dr Marwan Bukhari, Dr James Galloway and Prof John McBeth

09:00-10:30

Cardiac complications of rheumatic disease and anti-rheumatic therapies

Dr Taryn Youngstein, Dr Antonis Pantazis and Prof George Kitas

09:00-10:30

Framing the future of rheumatology specialist nurses and allied health professionals

Michael Backhouse, Di Finney and Louise Parker

09:00-10:30

Long-term outcome studies in paediatric and adolescent-onset autoimmune rheumatic disease: a closer look at JSLE, JDM and vasculitis

Dr Coziana Ciurtin, Dr Liza McCann and Dr Despina Eleftheriou

09:00-10:30

Specialised rheumatology commissioning network SIG

Dr Bridget Griffiths, Christopher Edwards and Dr Frances Hall

10:35-10:55

Poster showcase: Case reports

Dr Marwan Bukhari (chair)

10:35-10:55

Poster showcase: Rheumatoid arthritis

Dr Caroline Cotton (chair)

11:00-12:30

Droitwich Lecture and Barbara Ansell address: Young People Matter

Prof Anne-Maree Keenan and Dr Janet McDonagh

11:00-12:30

One size doesn’t fit all...

Dr Rosemary Hollick, Dr Benjamin Ellis and Dr Stuart Kyle

11:00-12:30

BSR guidelines in practice: practical advice and case studies of guideline implementation

Dr Edward Roddy, Dr Christopher Holroyd, Dr Ian Giles and Dr James Galloway

11:00-12:30

Disease assessment: oral abstracts

Dr Sinead Maguire, Dr Sayam Dubash, Dr Laura Tucker, Dr Varvara Choida and Dr Dale Webb

11:00-12:30

Experts in the field (Essentials session)

Prof Ida Haughen, Prof Michele Bombardieri and Dr Felix Woodhouse

12:30-13:30

Lunch

12:30-13:20

Lilly Symposium Session – Coast to Coast: a review of the efficacy and safety of Taltz®(ixekizumab) for the treatment of axSpA

Prof Bruce Kirkham and Prof Xenofon Baraliakos

12:30-13:20

Evolving rheumatology services to support PsA patients in a new world (Novartis organised promotional meeting discussing Novartis products. Prescribing information and adverse event reporting can be found at the meeting)

Dr Antoni Chan, Dr Kirsten MacKay, Julie Begum and Anusha Patel

Afternoon

Includes oral abstracts and Trainees session

TIME

SESSION

SPEAKERS

13:30-15:00

Osteoporosis and metabolic bone disease SIG

Prof Jon Tobias, Dr Kassim Javaid and Dr Nicola Crabtree

13:30-15:00

Life-threatening multi-system autoimmune rheumatic diseases

Dr Marina Anderson, Dr David D'Cruz and Dr Boris Lams

13:30-15:00

Sjögren’s: the spectrum of disease

Prof Michele Bombardieri, Prof Athimalaipet Ramanan and Dr Benjamin Fisher

13:30-15:00

COVID-19: the trainee experience (Trainees session)

Dr Elizabeth Reilly, Dr Chris Wincup, Dr Sasha Ali and Rosaria Salerno

13:30-15:00

Frailty, fatigue and depression: oral abstracts

Melissa Sweeney, Dr Susan Bridgewater, Michael Cook, Dr Caroline Flurey and Elena Zaballa

15:30-17:00

Feet are important to your patients – are they important to you?

Prof Anthony Redmond, Dr Lindsey Cherry and Dr Louise Warburton

15:30-17:00

Immunosuppression in the context of infections SIG

Dr David Lowe, Dr Alisdair MacConnachie and Dr Muddassir Shaikh

15:30-17:00

Quality improvement – building capacity and capitalising on opportunities to improve care SIG

Dr John Dean, Dr Ian Woolhouse and Gaby Ford

15:30-17:00

CTD and vasculitis: oral abstracts

Dr Graham Dinsdale, Dr Dalia Ludwig, Dr Trixy David, Dr Kristina Clark and Dr Lucy Carter

15:30-17:00

COVID-19: oral abstracts

Dr Natasha Cleaton, Nadezhda Tsurikova, Dr Chris Wincup, Dr Shirish Dubey and Dr Megan Rutter